CVC in talks to buy stake in Rovi's manufacturing business, Expansion reports
10/09/2024 07:50
MADRID, Sept 10 (Reuters) - Investment fund CVC CVC.AS
is in talks to buy a majority stake in Spanish pharmaceuticals
firm Rovi's ROVI.MC third-party manufacturing business,
Expansion newspaper reported on Tuesday, citing unidentified
market sources.
CVC is the only bidder left for the stake in the unit, which
is worth more than 3 billion euros ($3.31 billion), after other
potential investors who had filed non-binding offers withdrew
from the process, the newspaper said.
Spokespeople at Rovi and CVC did not immediately respond to
requests for comment.
Rovi said in June it had received several non-biding offers
for a business which has produced COVID-19 vaccines on behalf of
Moderna MRNA.O , among other drugs.
($1 = 0.9060 euros)
(Reporting by Inti Landauro; editing by Jason Neely)
((Inti.Landauro@thomsonreuters.com;))